Related Experiment Video
Updated: Feb 25, 2026

Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin
Published on: March 10, 2021
A tale of two tails: The importance of unstructured termini in the aggregation pathway of β2-microglobulin
Rui J S Loureiro1, Diogo Vila-Viçosa2, Miguel Machuqueiro2
1BioISI - Biosystems & Integrative Sciences Institute, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal.
Abstract:
The identification of intermediate states for folding and aggregation is important from a fundamental standpoint and for the design of novel therapeutic strategies targeted at conformational disorders. Protein human β2-microglobulin (HB2m) is classically associated with dialysis-related amyloidosis, but the single point mutant D76N was recently identified as the causative agent of a hereditary systemic amyloidosis affecting visceral organs. Here, we use D76N as a model system to explore the early stage of the aggregation mechanism of HB2m by means of an integrative approach framed on molecular simulations. Discrete molecular dynamics simulations of a structured-based model predict the existence of two intermediate states populating the folding landscape. The intermediate I1 features an unstructured C-terminus, while I2 , which is exclusively populated by the mutant, exhibits two unstructured termini. Docking simulations indicate that I2 is the key species for aggregation at acidic and physiological pH contributing to rationalize the higher amyloidogenic potential of D76N relative to the wild-type protein and the ΔN6 variant. The analysis carried out here recapitulates the importance of the DE-loop in HB2m self-association at a neutral pH and predicts a leading role of the C-terminus and the adjacent G-strand in the dimerization process under acidic conditions. The identification of aggregation hot-spots is in line with experimental results that support the importance of Phe56, Asp59, Trp60, Phe62, Tyr63, and Tyr66 in HB2m amyloidogenesis. We further predict the involvement of new residues such as Lys94 and Trp95 in the aggregation process.
Insights
Molecular simulations reveal two intermediate states in human β2-microglobulin (HB2m) aggregation. The D76N mutant forms a key aggregation species (I2), explaining its higher amyloidogenic potential and identifying new aggregation hot-spots.
Area of Science:
- Biophysics
- Molecular Biology
- Computational Chemistry
Background:
- Protein misfolding and aggregation are central to conformational disorders like amyloidosis.
- Human β2-microglobulin (HB2m) is linked to dialysis-related amyloidosis.
- The D76N HB2m mutant causes hereditary systemic amyloidosis, necessitating mechanistic understanding.
Purpose of the Study:
- To investigate the early aggregation mechanisms of the D76N HB2m mutant.
- To identify intermediate states and key aggregation species using molecular simulations.
- To elucidate the structural basis for the enhanced amyloidogenicity of the D76N mutant.
Main Methods:
- Discrete molecular dynamics simulations of a structure-based model.
- Computational docking simulations.
- Analysis of protein folding landscapes and intermediate states.
Main Results:
- Two intermediate states (I1 and I2) were predicted in the HB2m folding landscape.
- The D76N mutant exclusively populates the I2 intermediate, characterized by unstructured termini.
- I2 was identified as the key aggregation species at acidic and physiological pH, explaining the mutant's higher amyloidogenic potential.
- Specific regions (DE-loop, C-terminus, G-strand) and residues (Phe56, Asp59, Trp60, Phe62, Tyr63, Tyr66, Lys94, Trp95) were implicated in HB2m aggregation.
Conclusions:
- The D76N mutation significantly alters the HB2m aggregation pathway by stabilizing the I2 intermediate.
- Understanding these aggregation intermediates and hot-spots is crucial for designing targeted therapies for HB2m amyloidosis.
- The study provides a molecular basis for the distinct clinical manifestations of D76N-related amyloidosis.
Related Concept Videos
Protein Folding Quality Check in the RER
ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
Post-translational Translocation of Proteins to the RER
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
Export of Misfolded Proteins out of the ER
Termination of Translation
Intralumenal Vesicles and Multivesicular Bodies

